Alector Inc
Change company Symbol lookup
Select an option...
ALEC Alector Inc
MMS Maximus Inc
AAT American Assets Trust Inc
NBR Nabors Industries Ltd
CETY Clean Energy Technologies Inc
AAPL Apple Inc
GWRE Guidewire Software Inc
NXGN NextGen Healthcare Inc
NB NioCorp Developments Ltd
O Realty Income Corp
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a therapeutic approach for the treatment of neurodegeneration. The Company is engaged in developing therapies designed to counteract these pathologies by restoring healthy immune function to the brain. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration and immunology to identify immune system. The Company has advanced four product candidates, AL001, AL002, AL003, and AL101, into clinical development. Its first product candidate, AL001, is a humanized recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of frontotemporal dementia carrying a progranulin (FTD-GRN) patients. Its AL002 targets triggering receptor expressed on myeloid cells 2 (TREM2) to increase the functionality of TREM2 signaling and enhance microglia cell activation.

Postmarket

Last Trade
Delayed
$6.31
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$6.31
Day's Change
0.13 (2.10%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
6.43
Day's Low
6.11
Volume
(Light)
Volume:
340,122

10-day average volume:
763,994
340,122
  • Prev Close
    6.18
  • Today's Open
    6.15
  • Day's Range
    6.11-6.43
  • Avg Vol (10-day)
    764.0K
  • Last (time)
    4:00p ET 03/27/23
  • Last (size)
    28
  • 52-Wk Range
    5.76 - 15.39
    LowHigh
  • (03/30/22 - 03/24/23)
    9.55%
  • 71.2%
  • Market Cap
    523.9M
  • Shares Outstanding
    83.0M
  • -1.58
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.8
  • 79.81
  • (% of float 02/28/23)
    7.39

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.